Press Releases from DelveInsight (693 total)
Actinic Keratosis Pipeline: 10+ Key Players Driving Innovation in Non-Invasive D …
The actinic keratosis (AK) treatment landscape is expanding rapidly, driven by key players such as Biofrontera, Almirall, and Leo Pharma. The current pipeline includes next-generation…
Acinetobacter Infections Pipeline: 7+ Biopharma Players Combatting Antimicrobial …
Acinetobacter infections, especially those caused by Acinetobacter baumannii, remain a critical concern due to rising antimicrobial resistance. Leading biotech firms, such as Omnix Medical, Roche,…
Gaucher's Disease Type III Pipeline: 7+ Developers Advancing Targeted CNS Therap …
Gaucher's Disease Type III, the chronic neuronopathic form, is gaining targeted attention from over 7 companies, including Sanofi Genzyme, CANbridge Pharmaceuticals, AVROBIO, and Orphazyme. The…
Sandhoff Disease Pipeline: 5+ Biotech Firms Driving Rare Disease Innovation Thro …
Sandhoff Disease, a rare and fatal lysosomal storage disorder, is seeing progress through the efforts of over 5 companies, including IntraBio, Sanofi, Polaryx Therapeutics, and…
Lewy Body Disease Pipeline: 10+ Innovators Advancing Disease-Modifying and Sympt …
Lewy Body Disease (LBD), including dementia with Lewy bodies and Parkinson's disease dementia, is a complex neurodegenerative condition attracting the attention of over 10 key…
Klebsiella Infections Pipeline: 7+ Companies Targeting Multi-Drug Resistance wit …
With rising concerns over antibiotic-resistant Klebsiella strains, more than 7 companies are actively developing cutting-edge therapies, including Nosopharm, Debiopharm, and Locus Biosciences. The Klebsiella infections…
Norovirus Infection Pipeline: 8+ Leading Companies Advancing Breakthrough Vaccin …
The Norovirus infection pipeline is gaining momentum with 8+ pharmaceutical companies pursuing innovative solutions, including Prosit Sole Biotechnology, HilleVax, iosBio, and OstriGen. These players are…
The Global DNA Sequencing Market is Projected to Grow at a CAGR of ~18.02% by 20 …
The DNA sequencing market is experiencing robust growth fueled by several critical factors, including the rising incidence of genetic disorders and cancer, increasing applications of…
The Global Biopsy Devices Market Poised for Unstoppable Growth by 2032, Driven b …
The biopsy devices market is experiencing significant growth, fueled by key factors such as the increasing incidence of cancer and other chronic diseases, advancements in…
IgA Nephropathy Market Set for Exceptional Growth by 2034 - DelveInsight | Key P …
IgA Nephropathy, a leading cause of kidney disease worldwide, continues to challenge both patients and healthcare systems with its complex progression and limited treatment options.…
Pulmonary Arterial Hypertension Market Set for Remarkable Growth by 2034 - Delve …
Pulmonary Arterial Hypertension (PAH) is a progressive and life-threatening condition characterized by high blood pressure in the arteries of the lungs, leading to heart failure…
ENTYVIO Sales Surge Globally, Driven by Growing IBD Prevalence and Physician Dem …
DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" offers in-depth analysis of ENTYVIO sales, positioning, and market outlook across major geographies. Developed by Takeda…
Advanced Gastric Carcinoma Pipeline: 50+ Visionary Companies Pioneering the Next …
The advanced gastric carcinoma market is experiencing a wave of groundbreaking innovations, driven by pioneering companies such as GeneQuantum Healthcare (Suzhou), Janssen Pharmaceutical K.K., Shanghai…
Retinitis Pigmentosa Market Poised for Transformative Expansion by 2034 - DelveI …
Retinitis Pigmentosa, a group of inherited retinal disorders, continues to impose a significant burden on patients and healthcare systems worldwide. Driven by an increasing prevalence…
PD-1 and PD-L1 Inhibitors Competitive Landscape: 180+ Trailblazing Companies Red …
The PD-1 and PD-L1 inhibitors pipeline is on fire, with industry giants like Celgene, MedImmune, and Hangzhou Sumgen Biotech leading the charge. These game-changing immunotherapies…
Vestibular Schwannoma Pipeline: 10+ Pioneering Companies Revolutionizing Innovat …
The vestibular schwannoma treatment landscape is on the brink of a revolution, powered by disruptive therapies from pioneering companies like NeuroPharm and OrthoMed. With a…
Immunologic Deficiency Syndrome Pipeline: 40+ Visionary Companies Pioneering the …
The immunologic deficiency syndrome market is witnessing a surge in breakthrough innovations, spearheaded by trailblazers like Mustang Bio, Bellicum Pharmaceuticals, Lactiga, and GC Pharma. Cutting-edge…
Hepatitis C Virus Infection Pipeline: 20+ Leading Companies Shaping the Future o …
The Hepatitis C Virus (HCV) infection market is experiencing robust pipeline advancements, led by companies such as Genecure Biotechnologies Preclinical, iQur, and Atea Pharmaceutical. With…
Inflammatory Bowel Disease Market Set to Undergo Transformative Growth by 2034 - …
Inflammatory Bowel Disease, encompassing ulcerative colitis and Crohn's disease, continues to impose a significant burden on patients and healthcare systems worldwide. Driven by an increasing…
Homozygous Familial Hypercholesterolemia Market Poised for Transformative Growth …
Homozygous Familial Hypercholesterolemia (HoFH), a severe and ultra-rare genetic disorder, has long posed therapeutic challenges due to its aggressive cardiovascular complications and limited treatment options.…
Pyoderma Gangrenosum Market Set to Undergo Transformative Growth by 2032 - Delve …
Pyoderma gangrenosum, rare and painful neutrophilic dermatoses, is garnering growing clinical and research attention due to its complex pathogenesis and unmet therapeutic needs. With advancements…
Human Papillomavirus Market Set for Breakthrough Expansion by 2034, Driven by In …
Curious about the rapid evolution of the human papillomavirus market? DelveInsight's latest 7MM report uncovers crucial epidemiological patterns, transformative market trends, and highlights leading innovators…
Global Aesthetic Implants Market Set to Grow at a CAGR of 7.82% by 2032, Driven …
The aesthetic implants market is experiencing positive growth due to factors such as the increasing demand for cosmetic enhancement procedures, a growing aging population seeking…
Heart Failure Pipeline: 70+ Pioneering Companies Advancing the Next Wave of Inno …
The heart failure therapeutics and device market is experiencing a significant transformation, driven by key innovators such as Moderna Therapeutics, Cytokinetics, Applied Therapeutics, Help Therapeutics,…
Chronic Pulmonary Infections Pipeline: 10+ Leading Companies Driving the Next Wa …
The chronic pulmonary infections market is undergoing a significant transformation, driven by pioneering companies such as Chiesi Farmaceutici, Armata Pharmaceuticals, Genentech, Altesa Biosciences, and Kinaset…
ATTR Amyloidosis Pipeline: 10+ Leading Companies Shaping the Future of Groundbre …
The ATTR amyloidosis therapeutics market is witnessing a significant evolution, driven by trailblazing companies such as Novo Nordisk, Sirnaomics, and Arbor Bio. With the advent…
Alcohol Use Disorder Pipeline: 30+ Leading Companies Driving the Next Generation …
The Alcohol Use Disorder treatment market is undergoing a significant transformation, driven by trailblazers like Cybin, Indivio, BioXcel Therapeutics, BiocorRx Pharmaceuticals, Beckley Psytech, and MediciNova.…
Relapsing-Remitting Multiple Sclerosis Pipeline: 25+ Leading Innovators Paving t …
The relapsing-remitting multiple sclerosis (RRMS) therapeutics market is experiencing a significant transformation, driven by key innovators like Immunic AG, Sanofi, Anokion, RemeGen, HuniLife Biotechnology, Biogen,…
Atherosclerosis Pipeline: 15+ Trailblazing Companies Driving the Future of Innov …
The atherosclerosis market is experiencing a wave of therapeutic innovation, driven by key players such as Novo Nordisk, Amgen, Merck Sharp & Dohme, Afimmune, Silence…
Malaria Pipeline: 15+ Pioneering Companies Advancing the Next Wave of Innovative …
The malaria therapeutics and vaccine market is undergoing a critical transformation, led by innovators such as Sanaria, GlaxoSmithKline, Novartis, Bharat Biotech, and GeoVax. With the…
Hypercholesterolemia Pipeline: 25+ Leading Innovators Driving the Future of Chol …
The hypercholesterolemia market is being reshaped by biologics, RNA-based therapies, and gene-editing tools developed by industry leaders such as Amgen, Novartis, Verve Therapeutics, Arrowhead Pharmaceuticals,…
T-Cell Lymphoma Pipeline: 90+ Leading Companies Transforming the Landscape of Ta …
The T-cell lymphoma market is rapidly evolving with targeted therapies and immuno-oncology agents spearheaded by companies like Astex Pharmaceuticals, Corvus Pharmaceuticals, ViGenCell Inc., Affimed GmbH,…
Tuberculosis Pipeline: 30+ Innovators Paving the Way for Breakthrough Therapies …
The tuberculosis market is gaining renewed momentum with the development of advanced vaccines and novel drug regimens by key players such as Biofabri, Serum Institute…
Staphylococcal Infections Pipeline: 22+ Innovators Shaping the Future of Antibac …
Staphylococcal infections, caused by Staphylococcus bacteria, range from minor skin issues to severe conditions like pneumonia and sepsis. The rise of antibiotic-resistant strains, such as…
Sensorineural Hearing Loss Pipeline: 20+ Innovators Shaping the Future of Hearin …
The sensorineural hearing loss space is entering a transformative phase with groundbreaking innovations in gene therapy and regenerative medicine. Pioneering companies such as Sensorion, AudioCure…
Urticaria Pipeline: 20+ Innovators Driving the Next Wave of Advanced Treatment O …
The urticaria space is entering an exciting era of innovative treatment development, with leading companies such as Regeneron Pharmaceuticals, Taiho Pharmaceutical Co., Ltd, Allakos Inc,…
Treg Cell-Based Therapies Pipeline: 51+ Innovators Shaping the Future of Immunot …
The Treg cell-based therapy landscape is rapidly evolving, with pioneers like Orca Bio, Quell Therapeutics, Nektar Therapeutics, and Abata Therapeutics leading the charge in developing…
T-cell Malignancies Pipeline: 80+ Innovators Advancing the Next Wave of Targeted …
The T-cell malignancies pipeline is advancing rapidly, with leading companies such as Jiangsu Hengrui Medicine, Soligenix, Equillium, Janssen Biotech, Ono Pharmaceutical, and Artiva Biotherapeutics, pioneering…
Myotonic Dystrophy Pipeline: 20+ Innovators Pioneering the Next Generation of Pr …
The myotonic dystrophy space is entering an exciting chapter of RNA-targeted drug development, with trailblazers like Avidity Biosciences, Dyne Therapeutics, Ionis Pharmaceuticals, and ARTHEx Biotech…
Cell and Gene Therapy in Parkinson's Disease Pipeline: 18+ Innovators Shaping th …
The cell and gene therapy landscape in Parkinson's disease is undergoing a transformative evolution, led by pioneers like Sumitomo Dainippon Pharma, BlueRock Therapeutics, Aspen Neuroscience,…
Cough in Idiopathic Pulmonary Fibrosis Pipeline: 5+ Trailblazing Companies Advan …
The IPF cough therapy segment is gaining serious momentum, with players like Trevi Therapeutics, Cellular Sciences/Emphycorp, NeRRe Therapeutics, and Algernon Pharmaceuticals leveraging novel neuromodulatory approaches…
Advanced Merkel Cell Carcinoma Pipeline: 20+ Pioneering Innovators Redefining th …
The treatment paradigm for advanced Merkel cell carcinoma is being redefined through immunotherapy breakthroughs led by innovators such as Xencor, Incyte Corporation, Millennium Pharmaceuticals, Exelixis,…
Pneumococcal Infections Pipeline: 15+ Pioneering Companies Shaping the Next Gene …
The pneumococcal infection market is witnessing a surge in vaccine innovation, fueled by leaders such as CanSino Biologics, Pfizer, Merck Sharp & Dohme, EuBiologics, Beijing…
Panuveitis Therapeutics Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Panuveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Panuveitis, historical and forecasted epidemiology as well as the Panuveitis…
Waldenstrom's Macroglobulinemia Pipeline: Shaping the Future of Treatment with 2 …
The Waldenström's macroglobulinemia landscape is experiencing significant advancements, powered by cutting-edge research and transformative therapies. Leading biopharmaceutical companies like BeiGene, Janssen, Ascentage Pharma, Gilead Sciences,…
Cerebral Infarction Pipeline: Advancing Stroke Care with 20+ Innovators Transfor …
The cerebral infarction landscape is witnessing remarkable progress, fueled by groundbreaking research and innovative therapies. Leading biopharmaceutical companies such as RAstraZeneca, Athersys, NoNO, Materia Medica…
Advanced Urothelial Carcinoma Pipeline: Exploring Breakthroughs from 25+ Innovat …
The advanced urothelial carcinoma treatment landscape is undergoing a dynamic transformation, driven by novel mechanisms and breakthrough therapies. Leading biopharma innovators like Seagen, Astellas Pharma,…
Post-Polycythemia Vera Myelofibrosis Pipeline: Revolutionizing Treatment with Ov …
The Post-Polycythemia Vera Myelofibrosis (PPV-MF) landscape is undergoing significant advancements, driven by innovative research and new therapeutic strategies. Leading companies such as Parexel, Constellation Pharmaceuticals,…
Interstitial Lung Disease Pipeline: Transforming Treatment with 120+ Leading Inn …
The Interstitial Lung Disease (ILD) landscape is experiencing rapid advancements, fueled by innovative research and transformative breakthroughs. Leading companies like Roche, aTyr Pharma, Boehringer Ingelheim,…
Diffuse Large B-Cell Lymphoma Pipeline: 70+ Trailblazing Companies Driving the N …
The Diffuse Large B-Cell Lymphoma (DLBCL) market is on the brink of a transformative shift, fueled by the innovation of over 70 companies. More than…
